A California medical equipment company and its two owners have agreed to pay $825,000 to resolve federal allegations that they billed Medicare for braces and other equipment patients did not medically need or that were not properly prescribed.

Crown Medical Solutions LLC and owners Michelle and Philanzo King entered the civil settlement based on their ability to pay.

The case is a reminder that health care fraud does not have to involve a giant hospital chain or a billion-dollar laboratory scheme to take money from taxpayers.

The Justice Department’s Civil Division announced the settlement Sunday:

The Justice Department alleges that Crown submitted false Medicare claims from November 1, 2017, through April 30, 2019. The civil resolution covers the company and both of its owners, sets the recovery at $825,000, and awards the whistleblower approximately $123,750 for bringing the alleged scheme to the government’s attention.

ADVERTISEMENT

The claims involved durable medical equipment, including knee braces, back braces and heel stabilizers.

Federal officials say the items were medically unnecessary or had not been properly prescribed.

The settlement resolves the government’s civil False Claims Act allegations against the company and both owners. It was negotiated according to their ability to pay, and the department expressly notes that the allegations have not produced a determination of liability.

The department also credits the whistleblower provisions of federal law for bringing the alleged billing pattern to light and returning money to the Medicare program.

Those details matter because Medicare does not exist to finance warehouses full of equipment pushed through paperwork.

It exists to pay for care that eligible patients actually need.

Every unnecessary brace billed to the program drains money from seniors, workers and taxpayers. It also creates a record suggesting that a patient required treatment that may never have been clinically justified.

The company operated from Lemon Grove, California, and stopped doing business in April 2019.

The signed settlement agreement identifies Michelle King as Crown’s president and chief executive and Philanzo King as vice president. Each held a 50 percent ownership interest, placing the two owners directly inside the agreement alongside the company they controlled.

ADVERTISEMENT

The document lays out a payment schedule rather than a single check.

Crown and the Kings must pay $25,000 within 10 days of the agreement’s effective date. The remaining $800,000 carries interest at 4.25 percent and is scheduled to be paid through December 31, 2028.

The agreement says Crown’s principal place of business was in Lemon Grove and that the company stopped operating in April 2019, at the end of the period covered by the government’s allegations.

It also preserves the legal distinction between a negotiated civil resolution and a court finding, while creating an enforceable timetable for the defendants to satisfy the settlement amount.

A same-day account summarized the central allegation:

The case began with a whistleblower.

Karen Martinelli filed the action under the False Claims Act’s qui tam provisions, which allow private citizens with information about fraud to sue on behalf of the United States.

When the government recovers money, the whistleblower may receive a share.

Martinelli is expected to receive approximately $123,750, or 15 percent of the settlement.

ADVERTISEMENT

That incentive is one of the federal government’s most effective tools because insiders often see suspicious billing patterns before an investigator does.

They know when orders are being generated without genuine medical judgment. They know when forms are being treated as sales tickets and when a business model depends on Medicare paying before anyone asks why a patient needed the equipment.

Whistleblowers take real risks when they come forward. A system that rewards accurate information can save far more than it pays.

The settlement does not amount to a finding of liability. The claims are allegations, and the agreement states that there has been no determination that Crown or the Kings violated the law.

That legal distinction must remain clear.

But the government’s broader enforcement campaign is not slowing down.

President Donald Trump’s administration has placed health care fraud inside a larger effort to recover money lost through false claims, identity abuse, sham providers and medically unnecessary services.

The political message has been that no case is too small to pursue when taxpayer money is involved:

The dollar figure in that post reflects the author’s broader claim, not a number established by the Crown settlement.

ADVERTISEMENT

The policy principle, however, fits this case.

Fraud enforcement cannot focus only on the largest headline. Thousands of smaller false claims can quietly become a massive loss when the same playbook spreads across suppliers and states.

The Department of Health and Human Services inspector general says the 2026 national health care fraud takedown charged 455 defendants, including 90 medical professionals, in alleged schemes involving approximately $6.5 billion in false claims. That sweep provides national context for why federal agencies are examining billing behavior across providers, suppliers and medical professionals instead of limiting enforcement to a few spectacular cases.

The operation reached 56 federal districts across 45 states and territories.

Those charges are separate from the Crown civil settlement, but they show the size of the enforcement environment surrounding Medicare and other public health programs. The national operation joined investigators and prosecutors across jurisdictions rather than treating each suspicious claim as an isolated billing dispute.

Those numbers show why durable medical equipment deserves attention.

Braces, stabilizers and similar products are easy to describe as routine. That can make them attractive to operators who believe a small claim will disappear into an enormous federal program.

But scale changes the math.

A payment that looks modest by itself becomes serious money when it is multiplied across thousands of beneficiaries, repeated billing cycles and networks of marketers, prescribers and suppliers.

The government also needs to examine how the claims were approved.

If equipment was not properly prescribed, investigators should determine whether signatures were missing, copied, obtained through misleading solicitations or attached to patients who never had a legitimate clinical evaluation.

Medicare contractors should be able to detect unusual ordering patterns before payments continue for 18 months.

That means comparing suppliers, prescribers, diagnosis codes, geography and the number of braces ordered for each beneficiary. Modern data systems should flag a pattern before a whistleblower has to carry the entire burden.

The Crown settlement recovers money and rewards the person who brought the allegations forward.

It should also produce better prevention.

Taxpayers should not have to choose between prosecuting billion-dollar fraud rings and pursuing smaller operators. The same rule applies to both.

If a company bills Medicare for equipment that was not needed or properly prescribed, the government should follow the records, recover the money and expose the method.

An $825,000 recovery is one result in a much larger enforcement fight.

Every case that closes a billing route, protects a patient record and warns the next supplier makes the federal program harder to exploit.

What are your thoughts?

NATIONAL POLL: Do You Still Have Trump's Back 100%? vote now

TAP HERE TO ADD YOUR VOTE

 

Join The Conversation. Leave a Comment.